Kamada (KMDA) Other Non Operating Income (2013 - 2017)
Kamada (KMDA) posted quarterly Other Non Operating Income of -$11000.0 for Q4 2017, up 86.08% year-on-year from -$5911.6 in Q4 2016, and up 86.08% on a QoQ basis from -$79000.0 in Q4 2016.
Kamada (KMDA) Other Non Operating Income (2013 - 2017) Analysis & Trends
Kamada (KMDA) has reported Other Non Operating Income for 5 consecutive years, with -$11000.0 the latest figure, recorded in Q4 2017.
- Quarterly Other Non Operating Income rose 86.08% year-over-year to -$11000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $126000.0 (up 270.27% YoY) and the FY2017 annual result came in at $73000.0, up 380.77% from the prior year.
- Other Non Operating Income grew to -$11000.0 in Q4 2017 per KMDA's latest filing, from -$79000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for KMDA reached as high as $399000.0 in Q2 2015 and fell as low as -$211000.0 in Q3 2014.
- A 5-year average of -$42142.9 and a median of -$102000.0 in 2014 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2014 — Other Non Operating Income gained 5.56% — and 2015, when it surged 491.18%.
- Year by year, Other Non Operating Income stood at -$108000.0 in 2013, then slumped by 95.37% to -$211000.0 in 2014, then climbed by 13.27% to -$183000.0 in 2015, then jumped by 56.83% to -$79000.0 in 2016, then surged by 86.08% to -$11000.0 in 2017.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$11000.0, -$79000.0, and -$183000.0 for Q4 2017, Q4 2016, and Q3 2015 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -11,000.00 |
| Dec 31, 2016 | -79,000.00 |
| Sep 30, 2015 | -183,000.00 |
| Jun 30, 2015 | 399,000.00 |
| Sep 30, 2014 | -211,000.00 |
| Jun 30, 2014 | -102,000.00 |
| Jun 30, 2013 | -108,000.00 |